Design Therapeutics (DSGN) Other Non Operating Income (2020 - 2024)
Design Therapeutics (DSGN) posted quarterly Other Non Operating Income of $3.2 million for Q3 2024, up 5.74% year-over-year from $3.0 million in Q4 2023, and down 1.32% on a QoQ basis from $3.2 million in Q2 2024.
Design Therapeutics (DSGN) Other Non Operating Income (2020 - 2024) Analysis & Trends
Design Therapeutics has reported Other Non Operating Income for 5 years, with the latest figure at $3.2 million in Q3 2024.
- Other Non Operating Income for Q3 2024 came in at $3.2 million, up 5.74% year-over-year; the trailing twelve-month figure through Sep 2024 was $13.0 million (up 29.01% YoY), and the FY2023 annual result was $11.3 million, up 164.36% from the prior year.
- Other Non Operating Income eased to $3.2 million in Q3 2024, from $3.2 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $3.3 million in Q1 2024 and troughed at -$40000.0 in Q1 2020.
- A 5-year average of $1.4 million and a median of $640000.0 in 2022 frame the typical range for Other Non Operating Income.
- The widest annual swing landed in 2021, when Other Non Operating Income plunged 69.84%; it then soared 7731.58% in 2022.
- A 5-year view of Other Non Operating Income shows it stood at $6000.0 in 2020, then jumped by 933.33% to $62000.0 in 2021, then surged by 3209.68% to $2.1 million in 2022, then jumped by 59.8% to $3.3 million in 2023, then dropped by 2.2% to $3.2 million in 2024.
- Per Business Quant data, the three most recent Other Non Operating Income figures were $3.2 million in Q3 2024, $3.2 million in Q2 2024, and $3.3 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Design Therapeutics | 928.06 Mn | 720.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 3.21 Mn |
| Jun 30, 2024 | 3.25 Mn |
| Mar 31, 2024 | 3.30 Mn |
| Dec 31, 2023 | 3.28 Mn |
| Sep 30, 2023 | 3.03 Mn |
| Jun 30, 2023 | 2.66 Mn |
| Mar 31, 2023 | 2.36 Mn |
| Dec 31, 2022 | 2.05 Mn |
| Sep 30, 2022 | 1.49 Mn |
| Jun 30, 2022 | 640,000.00 |
| Mar 31, 2022 | 105,000.00 |
| Dec 31, 2021 | 62,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Jun 30, 2021 | 51,000.00 |
| Mar 31, 2021 | 166,000.00 |
| Dec 31, 2020 | 6,000.00 |
| Sep 30, 2020 | 63,000.00 |
| Jun 30, 2020 | 21,000.00 |
| Mar 31, 2020 | -40,000.00 |